Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer
Year: 2024
Type: article
Study design: Observational Study
Abstract: Fluorine 18 prostate-specific membrane antigen 1007 PET/CT showed good sensitivity and moderate specificity for the detection of clinically significant prostate cancer, effectively ruling this out in 93% of participants with Prostate Imaging Reporting and Data System category 3 lesions.
Source: Radiology
Authors: Bastiaan M. Privé, Bas Israël, Marcel J. R. Janssen, Marloes M. G. van der Leest, Maarten de Rooij, Jolique A. van Ipenburg, Marianne Jonker, Steffie M. B. Peters, Michel de Groot, Patrik Zámecnik, Alexander Hoepping, Joyce G. Bomers, Martin Gotthardt, J. P. Michiel Sedelaar, Jelle O. Barentsz, Inge M. van Oort, James Nagarajah
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4398176419
